Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.

[1]  R. Dummer,et al.  The Genetic Evolution of Melanoma from Precursor Lesions. , 2015, The New England journal of medicine.

[2]  Steven J. M. Jones,et al.  Genomic Classification of Cutaneous Melanoma , 2015, Cell.

[3]  Trevor J Pugh,et al.  Oncotator: Cancer Variant Annotation Tool , 2015, Human mutation.

[4]  R. Melamed,et al.  FBXW7 mutations in melanoma and a new therapeutic paradigm. , 2014, Journal of the National Cancer Institute.

[5]  N. Dhomen,et al.  Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53 , 2014, Nature.

[6]  X. Su,et al.  NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. , 2014, The Journal of investigative dermatology.

[7]  Raul Rabadan,et al.  SAVI: a statistical algorithm for variant frequency identification , 2013, BMC Systems Biology.

[8]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[9]  K. Flaherty,et al.  Elucidating distinct roles for NF1 in melanomagenesis. , 2013, Cancer discovery.

[10]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[11]  Jan V Hirschmann,et al.  Lower limb cellulitis and its mimics: part I. Lower limb cellulitis. , 2012, Journal of the American Academy of Dermatology.

[12]  A. Sivachenko,et al.  A Landscape of Driver Mutations in Melanoma , 2012, Cell.

[13]  Matthew J. Davis,et al.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.

[14]  K. Duffy,et al.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. , 2012, Journal of the American Academy of Dermatology.

[15]  K. Duffy,et al.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. , 2012, Journal of the American Academy of Dermatology.

[16]  L. Chin,et al.  Melanoma: from mutations to medicine. , 2012, Genes & development.

[17]  T. Fennell,et al.  Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.

[18]  C. V. Jongeneel,et al.  Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma , 2011, Nature Genetics.

[19]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[20]  David E Elder,et al.  Dysplastic naevi: an update , 2010, Histopathology.

[21]  R. DePinho,et al.  BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.

[22]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[23]  H. Kerl,et al.  Non-random spatial association of melanoma and naevi--a morphometric analysis. , 1999, Melanoma research.

[24]  A. Marghoob,et al.  Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. , 1995, Journal of the American Academy of Dermatology.